Gilead Sciences (GILD) P/S (1999 - 2026)
Gilead Sciences (GILD) P/S from Nov 1, 1999 to Jul 21, 2026. The TTM Gilead Sciences (GILD) P/S is 5.44. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Gilead Sciences (GILD)
| Year | P/S | Change |
|---|---|---|
| 2026 | 5.44 | +5.18% |
| 2025 | 5.17 | +29.25% |
| 2024 | 4.00 | +8.53% |
| 2023 | 3.69 | -7.04% |
| 2022 | 3.97 | +18.97% |
| 2021 | 3.33 | +12.69% |
| 2020 | 2.96 | -19.25% |
| 2019 | 3.66 | +1.12% |
| 2018 | 3.62 | +6.35% |
| 2017 | 3.41 | +13.66% |
| 2016 | 3.00 | -31.99% |
| 2015 | 4.41 | -22.34% |
| 2014 | 5.68 | -44.82% |
| 2013 | 10.29 | +78.89% |
| 2012 | 5.75 | +52.07% |
| 2011 | 3.78 | +1.72% |
| 2010 | 3.72 | -33.05% |
| 2009 | 5.55 | +403.00% |
| 2008 | 1.10 | +14.89% |
| 2007 | 0.96 | +41.72% |
| 2006 | 0.68 | +23.51% |
| 2005 | 0.55 | +50.24% |
| 2004 | 0.37 | +20.08% |
| 2003 | 0.30 | +71.41% |
| 2002 | 0.18 | +3.47% |
| 2001 | 0.17 | +58.47% |
| 2000 | 0.11 | +53.22% |
| 1999 | 0.07 | N/A |
Comparison Gilead Sciences (GILD) P/S with competitors
Gilead Sciences (GILD) P/S is 5.44.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -89.43% |
| NVO | Novo Nordisk | 0.66 | -87.83% |
| GRFS | Grifols SA | 0.67 | -87.67% |
| AMRN | Amarin Corp | 1.39 | -74.46% |
| SCLX | Scilex Holding Company | 1.92 | -64.81% |
| SNY | Sanofi | 2.18 | -59.88% |
| PFE | Pfizer Inc | 2.18 | -59.88% |
| BMY | Bristol-Myers Squibb Company | 2.40 | -55.91% |
| BIIB | Biogen Inc | 2.93 | -46.15% |
| GSK | GSK Plc | 3.22 | -40.75% |
| MRK | Merck & Co Inc | 4.54 | -16.64% |
| AZN | Astrazeneca plc | 4.58 | -15.74% |
| NVS | Novartis AG | 5.07 | -6.83% |
| AMGN | AMGEN Inc | 5.15 | -5.36% |
| JNJ | Johnson & Johnson | 6.34 | +16.51% |
| ABBV | Abbvie Inc | 7.15 | +31.40% |
| LLY | Lilly(Eli) & Company | 14.28 | +162.43% |